Table. Residual disease measured as ratio BCR-ABL/ABL transcripts according to time in complete remission (CR) in 40 nonrelapsing patients continuing IFN therapy

Time in CR Number of Samples (n)Ratio BCR-ABL/ABL (%)
Median Range
Fewer than 0.5 years  27  0.460  0.0002-4.5  
0.5-1 year  22 0.135  0.003-2.1  
1-2 years  29  0.040  0-1.2 
2-3 years  26  0.030  0.002-0.9  
3-5 years  22 0.020  0.003-0.33  
More than 5 years  27  0.015  0-0.36  
All samples  153 0.040  0-4.5 
Time in CR Number of Samples (n)Ratio BCR-ABL/ABL (%)
Median Range
Fewer than 0.5 years  27  0.460  0.0002-4.5  
0.5-1 year  22 0.135  0.003-2.1  
1-2 years  29  0.040  0-1.2 
2-3 years  26  0.030  0.002-0.9  
3-5 years  22 0.020  0.003-0.33  
More than 5 years  27  0.015  0-0.36  
All samples  153 0.040  0-4.5 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal